Page last updated: 2024-08-16

(3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and Sensitivity and Specificity

(3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone has been researched along with Sensitivity and Specificity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, BC; Chen, P; Chen, X; Gillooly, KM; Hynes, J; Kiener, PA; Leftheris, K; McIntyre, KW; Norris, DJ; Pandit, C; Patil-Koota, V; Shuster, DJ; Turk, LA; Wu, H; Zhao, R1

Other Studies

1 other study(ies) available for (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and Sensitivity and Specificity

ArticleYear
C-3 Amido-indole cannabinoid receptor modulators.
    Bioorganic & medicinal chemistry letters, 2002, Sep-02, Volume: 12, Issue:17

    Topics: Amides; Animals; Anti-Inflammatory Agents; Cell Line; Humans; Immunity, Cellular; Indoles; Inhibitory Concentration 50; Leukocytes, Mononuclear; Lipopolysaccharides; Mice; Protein Binding; Receptors, Cannabinoid; Receptors, Drug; Sensitivity and Specificity; Structure-Activity Relationship; Tumor Necrosis Factor-alpha

2002